Načítá se...
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review
PURPOSE: Polygenic risk influences susceptibility to cancer. We assessed whether polygenic risk scores could be used in conjunction with other predictors of future disease status in costeffective risk-stratified screening for cancer. METHODS: We undertook a systematic review of papers that evaluated...
Uloženo v:
| Vydáno v: | Genet Med |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2022
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7614235/ https://ncbi.nlm.nih.gov/pubmed/35575786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gim.2022.04.020 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|